Clinical Trials List
Protocol NumberD763TC00001
Not yet recruiting
2026-06-01 - 2032-12-31
Phase III
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/06/01
Investigators and Locations
Co-Principal Investigator
- Tzu-Hsiang Hsu Division of Urology
- 蔡承翰 Division of Urology
- 陳人傑 Division of Urology
- Tzu-chun Wei Division of Urology
- Hsiao-Jen Chung Division of Urology
- Tzu-Hao Huang Division of Urology
- 沈書慧 Division of Radiology
- Yen-Hwa Chang Division of Urology
- 柯玉潔 Division of Ophthalmology
- 陳威任 Division of Urology
- Chih-Chieh Lin Division of Urology
- Ming-Hsuan Ku Division of Urology
Co-Principal Investigator
- Kuan-Yu Wu Division of Urology
- 詹皓程 Division of Urology
- 戴大堯 Division of Urology
- 鍾秉軒 Division of Hematology & Oncology
- 謝宜珈 Division of Urology
- Wen-Pin Su Division of Hematology & Oncology
- Che-Yuan Hu Division of Urology
Co-Principal Investigator
- 黃文冠 Division of Hematology & Oncology
- I-hung Shao Division of Urology
- Yung-Chang Lin Division of Hematology & Oncology
- 張杰茵 Division of Hematology & Oncology
- 蘇安琪 Division of Radiology
- Chun-Te Wu Division of Urology
- Yung-Chia Kao Division of Hematology & Oncology
- 余紹銘 Division of Hematology & Oncology
- Kai-Jie Yu Division of Urology
- 李宗霖 Division of Urology
- PO-HUNG LIN Division of Urology
- See-Tong Pang Division of Urology
- Hong-Cheng Gan Division of Urology
Co-Principal Investigator
- Tsu-Ming Chien Division of Urology
- Ching-Chia Li Division of Urology
- 張顥瀚 Division of Urology
- Hung-Lung Ke Division of Urology
- 阮雍順 Division of Urology
- 盧嘉文 Division of Urology
- Hsiang Ying Lee Division of Urology
- Sheng-Chen Wen Division of Urology
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
32 participants
-
Global
915 participants
